One-year mortality after acute myocardial infarction prior to and after the implementation of a widespread use of thrombolysis and aspirin. Experiences from the community of Goteborg, Sweden

Cardiology

Volumn 89, Issue 3, 1998, Pages 216-221

  Herlitz, Johan ^a   Hartford, Marianne ^a   Karlson, Björn W ^a   Dellborg, Mikael ^a   Källström, Gerd ^a   Karlsson, Thomas ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Acute myocardial infarction; Aspirin; Coronary care unit; Mortality; Thrombolysis

Indexed keywords

ACETYLSALICYLIC ACID; FIBRINOLYTIC AGENT;

ACUTE HEART INFARCTION; AGED; ARTICLE; BLOOD CLOT LYSIS; CORONARY CARE UNIT; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; ONSET AGE; PRIORITY JOURNAL; SWEDEN;

AGED; ASPIRIN; CORONARY CARE UNITS; FEMALE; FIBRINOLYTIC AGENTS; FOLLOW-UP STUDIES; HOSPITALS, COMMUNITY; HUMANS; MALE; MYOCARDIAL INFARCTION; PLATELET AGGREGATION INHIBITORS; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; SWEDEN; THROMBOLYTIC THERAPY;

EID: 0031881660     PISSN: 00086312     EISSN: None     Source Type: Journal    
DOI: 10.1159/000006790     Document Type: Article

References (22)

1. Hopper JL, Pathik B, Hunt D, Chan WW: Improved prognosis since 1969 of myocardial infarction treated in a coronary care unit: Lack of relation with changes in severity. Br Med J 1989;299:892-896.
2. Dellborg M, Eriksson P, Riha M, et al: Declining hospital mortality in acute myocardial infarction. Eur Heart J 1994;15:5-9.
3. Wennerblom B, Holmberg S, Wedel H: The effect of a mobile coronary care unit on mortality in patients with acute myocardial infarction or cardiac arrest outside hospital. Eur Heart J 1982;3:504-515.
4. Herlitz J, Hjalmarson Å: The role of betablockade in the limitation of infarct development. Br Heart J 1986;7:475-481.
5. Taylor SH: Left ventricular failure complicating acute myocardial infarction - Problems and potential of non-thrombolytic therapy. Cardiology 1988;75:67-89.
6. ISIS-1 (First International Study of Infarct Survival) Collaborative Group: Randomised trial of intravenous atenolol among 16,027 cases of suspected acute myocardial infarction. Lancet 1986;ii:57-66.
7. Jugdutt BI, Warnica JW: Intravenous nitroglycerin therapy to limit myocardial infarct size, expansion and complications. Circulation 1988;78:906-918.
8. The GISSI Group: Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1986;1:397-401.
9. ISIS-2 Collaborative Group: Randomised trial of intravenous streptokinase, oral aspirin, both or neither among 17,187 cases of suspected acute myocardial infarction. Lancet 1988;ii: 349-360.
10. The Thrombolysis Early in Acute Heart Attack Trial Study Group: Very early thrombolytic therapy in suspected acute myocardial infarction. Am J Cardiol 1990;65:401-407.
11. Smith P, Arnesen H: Non-respondents in a postmyocardial infarction trial: Characteristics and reasons for refusal. Acta Med Scand 1988; 223:537-542.
12. Smith P, Arnesen H: Mortality in non-consenters in a post-myocardial infarction trial. Acta Med Scand 1988;228:253-256.
13. Wilcox RG, von der Lippe G, Olsson CG, Jensen G, Skene AM, Hampton JR: Effects of alteplase in acute myocardial infarction: 6-month results from the ASSET study. Lancet 1990; 335:1175-1178.
14. Aspirin Myocardial Infarction Study Group: A randomized controlled trial of aspirin in persons recovering from myocardial infarction. JAMA 1980;243:661-669.
15. Karlson BW, Herlitz J, Wildund O, Pettersson P, Hallgren P, Hjalmarson Å: Characteristics and prognosis of patients with acute myocardial infarction in relation to whether they were treated in the coronary care unit or in another ward. Cardiology 1992;81:134-144.
16. Karlson BW, Herlitz J, Edvardsson N, Emanuelsson H, Sjölin M, Hjalmarson Å: Eligibility for intravenous thrombolysis in suspected acute myocardial infarction. Circulation 1990; 82:1140-1146.
17. Herlitz J, Hartford M, Blohm M, et al: Effect of a media campaign on delay times and ambulance use in suspected acute myocardial infarction. Am J Cardiol 1989;64:90-93.
18. Ziljstra F, deBoer MJ, Hoorntje CA, et al: A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction. N Engl J Med 1993;328: 680-684.
19. Grines CL, Browne KF, Marco J, et al: A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. N Engl J Med 1993;328:673-679.
20. Gibbons RJ, Holmes DR, Reeder GS, et al, for the Mayo Coronary Care Unit and Catheterization Laboratory Groups: Immediate angioplasty compared with the administration of a thrombolytic agent followed by conservative treatment for myocardial infarction. N Engl J Med 1993;328:685-691.
21. Ranjadayalan K, Umachandran V, Timmis AD: Clinical impact of introducing thrombolytic and aspirin therapy into the management policy of a coronary care unit. Am J Med 1992; 92:233-238.
22. Every NR, Larson EB, Litwin PE, Maynard C, Fihn SD, Eisenberg MS, et al, for the Myocardial Infarction Triage and Intervention Project Investigators: The association between on-site cardiac catheterization facilities and the use of coronary angiography after acute myocardial infarction. N Engl J Med 1993;329:546-551.